Matthias Amrein

Biography

Dr. Amrein is the founder of SolAeroMed’s S1229 drug technology.  He is a professor at the Faculty of Medicine, University of Calgary, Snyder Institute for Chronic Diseases, Airway Inflammation Research Group (AIRG). He studied at the Swiss Federal Institute of Technology, Zurich (ETH) with a doctorate from a joint venture between the IBM research lab in Rueschlikon (group of Nobel Laureate Heinrich Rohrer) and ETH, where he was the first to successfully apply the then new scanning probe technique (STM, AFM) to the biomedical area. In his current function as a member of the AIRG, he credits his group with discovering the main mechanism of pulmonary surfactant dysfunction with a treatment in pre-clinical testing. He is the director of the Microscopy and Imaging Facility (MIF), University of Calgary. This University wide facility for electron-, atomic force- and super resolution light microscopy serves researchers from more than 100 industry and academic labs from medicine, biological sciences and engineering. Dr. Amrein is the founder of SolAeroMed’s S1229 drug technology.  He is a professor at the Faculty of Medicine, University of Calgary, Snyder Institute for Chronic Diseases, Airway Inflammation Research Group (AIRG). He studied at the Swiss Federal Institute of Technology, Zurich (ETH) with a doctorate from a joint venture between the IBM research lab in Rueschlikon (group of Nobel Laureate Heinrich Rohrer) and ETH, where he was the first to successfully apply the then new scanning probe technique (STM, AFM) to the biomedical area. In his current function as a member of the AIRG, he credits his group with discovering the main mechanism of pulmonary surfactant dysfunction with a treatment in pre-clinical testing. He is the director of the Microscopy and Imaging Facility (MIF), University of Calgary. This University wide facility for electron-, atomic force- and super resolution light microscopy serves researchers from more than 100 industry and academic labs from medicine, biological sciences and engineering.

Research Interest

Pharmaceutical Sciences